Why does the ATG approval status dictate so much of this company's value? Am I the only one who sees a company with plenty of money in the bank working on penetrating large growing global diagnotics markets? Who cares about selling a few self tests, that's not going to make AT1 a multi billion dollar company - its patented technology and vision might though... The share price shouldn't move more than 10% up or down based on local matters like these.
Why does the ATG approval status dictate so much of this...
-
- There are more pages in this discussion • 106 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
